Recent Posts

1. 

   Good luck to all -- hell is coming on the 22nd

   Yeah but the problem is that they'd just fvck it up in commercial execution - just like all the other recent launches and "great products" in the past 4 years.

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 11:06 AM

2. 

   Investors > employees

   All employees (or "resources") are expendable. No one is valued for anything.

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 11:03 AM

3. 

   The final countdown…

   Which are what? Everything I’ve seen it’s a very clean drug with no movement side effects.

   Alkermes

   anonymous

   Apr 26, 2024 at 11:00 AM

4. 

   Bring Anthony Mancini back as CEO

   Spot on......he never mentally expanded his vision beyond a product manager from 2008.

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 11:00 AM

5. 

   Sotyktu floundering

   If the product was great then it would be producing great revenues. Fact is the dermatology prescribers don't like Sotyktu. Most will tell you it's the side effect profile. It's too similar to a JAK. You can't overcome product labeling. BMY...

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 10:59 AM

6. 

   Shortages and outages for Mounjaro and Zepbound

   Exactly! How long before announcement on sales force restructuring? Early buyout for those over 50? Joining pc1/2 and spec rep territories?

   Eli Lilly

   anonymous

   Apr 26, 2024 at 10:56 AM

7. 

   401k Defined Contribution 27% Haircut

   Interesting way to pay for the NSM

   Astellas

   anonymous

   Apr 26, 2024 at 10:48 AM

8. + Show More